TOPROL-XL metoprolol succinate 23.75mg controlled release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

toprol-xl metoprolol succinate 23.75mg controlled release tablet blister pack

astrazeneca pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: silicon dioxide; ethylcellulose; hyprolose; microcrystalline cellulose; sodium stearylfumarate; synthetic paraffin; macrogol 6000; hypromellose; titanium dioxide - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOBETA-XL metoprolol succinate 23.75 mg modified release tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

tobeta-xl metoprolol succinate 23.75 mg modified release tablet bottle pack

pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; ethylcellulose; triethyl citrate; silicified microcrystalline cellulose; methacrylic acid copolymer; sodium stearylfumarate; macrogol 6000; povidone; purified talc; croscarmellose sodium; silicon dioxide; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOPRELOC-XL metoprolol succinate 23.75 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

topreloc-xl metoprolol succinate 23.75 mg modified release tablet blister pack

pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: macrogol 6000; ethylcellulose; sodium stearylfumarate; silicon dioxide; triethyl citrate; microcrystalline cellulose; purified talc; methacrylic acid copolymer; croscarmellose sodium; povidone; silicified microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOPRELOC-XL  metoprolol succinate 23.75 mg modified release tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

topreloc-xl metoprolol succinate 23.75 mg modified release tablet bottle

pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: triethyl citrate; macrogol 6000; croscarmellose sodium; povidone; sodium stearylfumarate; purified talc; silicon dioxide; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOBETA-XL metoprolol succinate 23.75 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

tobeta-xl metoprolol succinate 23.75 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: purified talc; macrogol 6000; microcrystalline cellulose; povidone; silicon dioxide; triethyl citrate; sodium stearylfumarate; croscarmellose sodium; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Myloc CR New Zealand - English - Medsafe (Medicines Safety Authority)

myloc cr

viatris limited - metoprolol succinate 23.75mg equivalent to 9.71 mg free drug base;  ;   - modified release tablet - 23.75 mg - active: metoprolol succinate 23.75mg equivalent to 9.71 mg free drug base     excipient: colloidal silicon dioxide hypromellose macrogol 6000   magnesium stearate microcrystalline cellulose polyacrylate dispersion 30% povidone purified talc   sugar spheres titanium dioxide - hypertension. to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. paediatric hypertension

Metoprolol Retard Viatris  23.75 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

metoprolol retard viatris 23.75 mg tabl. prol.-rel.

viatris gx bv-srl - metoprolol succinate 23,75 mg - eq. metoprolol tartrate 25 mg - prolonged-release tablet - 23,75 mg - metoprolol succinate 23.75 mg - metoprolol

Selozok 25 23,75 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

selozok 25 23,75 mg tabl. prol.-rel.

recordati ireland ltd. - metoprolol succinate 23,75 mg - prolonged-release tablet - 23,75 mg - metoprolol succinate 23.75 mg - metoprolol

23.4% SODIUM CHLORIDE INJECTION USP SOLUTION Canada - English - Health Canada

23.4% sodium chloride injection usp solution

baxter corporation - sodium chloride - solution - 23.4% - sodium chloride 23.4% - replacement preparations